71
Participants
Start Date
July 11, 2022
Primary Completion Date
October 31, 2026
Study Completion Date
December 31, 2026
18F-FGLN PET Imaging
PET/CT Imaging: The study visit will take around 3-4 hours, the duration of PET will be around 90 minutes. Women should have negative pregnancy test prior to the study. An intravenous catheter will be placed in the subject's opposite arm, which will be used for radiotracer administration. A low-dose helical CT scan will be performed during a \~15 sec inspiratory breath hold and used for CT-based attenuation correction of PET emission data and as an anatomical reference for image analyses. Participants will be retained in the PET facility following the PET scan to promote urination to increase elimination of the radiotracer.
(18F)FPGLU
\[F-18\]FGln is a natural glutamine derivative was synthesized to explore its potential application of imaging glutamine uptake for cancer diagnosis. The proposed research study will provide preliminary evidence of the potential to utilize \[F-18\]FGln as a non-invasive imaging biomarker of glutamine flux and metabolism across a range of PAH subjects.
RECRUITING
Montefiore Hospital Clinical and Translational Research Center, Pittsburgh
Collaborators (1)
Bayer
INDUSTRY
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Stephen Y. Chan
OTHER